Iliac Stents Market - By Type (Self-expandable, Balloon-Expandable, Covered Stents), Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions), End-use (Hospital, ASCs), & Global Forecast 2024 - 2032

Iliac Stents Market - By Type (Self-expandable, Balloon-Expandable, Covered Stents), Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions), End-use (Hospital, ASCs), & Global Forecast 2024 - 2032

Global Iliac Stents Market will grow at 5% CAGR during 2024-2032, driven by the growing elderly population globally and advancements in medical technologies.

The rising incidences of cardiovascular diseases globally serve as a significant growth driver for the market. According to the World Heart Federation, over half a billion people globally remain impacted by cardiovascular diseases in 2023. Cardiovascular diseases, including arterial stenosis and occlusion, are prevalent due to factors such as sedentary lifestyles, unhealthy diets, and aging populations. As the incidence of these conditions continues to rise, the demand for effective treatment options such as iliac stenting also increases.

This trend is particularly pronounced in developing regions experiencing demographic and epidemiological transitions. Additionally, advancements in medical technology have improved the efficacy and accessibility of iliac stenting procedures, further driving market growth. Healthcare providers are adopting minimally invasive techniques for treating cardiovascular conditions, which also contributes to market expansion.

The Iliac Stents industry is classified based on type, artery lesions, end-use, and region.

Severe calcified lesions segment will grow rapidly till 2032, as they pose a substantial challenge during endovascular interventions, necessitating the use of specialized stenting solutions. The rising prevalence of arterial calcification, particularly in aging populations, is driving the demand for advanced stenting solutions capable of effectively treating these challenging lesions. Manufacturers are focusing on developing stents with enhanced deliverability and radial strength to address the specific needs of patients with severe calcified lesions. Moreover, the increasing adoption of minimally invasive procedures, coupled with the rising awareness among healthcare professionals about the benefits of endovascular interventions, is expected to further fuel the demand for iliac stents designed for severely calcified lesions.

Balloon-expandable stents segment will grow at a fast pace till 2032, as they offer precise deployment, excellent conformability, and the ability to achieve optimal stent expansion in complex anatomies. These stents are particularly well-suited for treating iliac artery stenosis, offering superior outcomes compared to alternative stent designs. The growing adoption of minimally invasive procedures and advancements in stent delivery systems are further driving the demand for balloon-expandable iliac stents. Market players are investing in R&D activities to introduce innovative balloon-expandable stents with enhanced features and improved clinical outcomes.

Europe Iliac stents industry will witness a steady growth till 2032, attributed to the presence of a well-established healthcare infrastructure, increasing healthcare expenditure, and a high prevalence of cardiovascular diseases. Additionally, favorable reimbursement policies and initiatives aimed at promoting minimally invasive procedures are driving the adoption of iliac stents in the region. Market players are focusing on expanding their presence through strategic collaborations, partnerships, and product launches to capitalize on the growing demand for iliac stents in the region. Furthermore, the aging population, coupled with lifestyle changes leading to a higher incidence of cardiovascular conditions, is expected to contribute to the sustained growth of the iliac stents market in the region.